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1. Introduction 
Most human hemoglobin variants arise from a single 
amino acid substitution of either chain. Hemoglobin 
C Harlem was the first to be described which contains 
two amino acid substitutions in the /3 polypeptide 
chain, and which differs electrophoretically from Hb 
S and yet causes sickling [ 11. An cy chain variant, Hb 
J Singapore [2] exhibits changes at two adjoining 
positions in the (Y chain. The present report is con- 
cerned with a new hemoglobin variant, designated Hb 
C Ziguinchor, which is associated with erythrocyte 
sickling and which contains both the ‘sickle’ mutation 
fib Glu + Val, and a second amino acid substitution 
f15’ Pro -+ Arg in the p polypeptide chain, as in hemo- 
globin Dhofar [3] or Yukahashi [4]. In this paper we 
give a description of the studies leading to this struc- 
tural formulation. 
2. Material and methods 
The abnormal hemoglobin was detected in a 40 
year old African negro man under investigation at the 
Hbpital Principal de Dakar. 
The procedures used for the identification of the 
abnormal hemoglobin were electrophoresis in various 
buffers and media [ 51, and isoelectric focusing on 
polyacrylamide gel [6]. Heat stability tests and solu- 
bility determinations were carried out in either isopro- 
panol [7] or concentrated phosphate [8] as previously 
described. Hb C Ziguinchor was isolated by DEAE 
cellulose chromatography [9] and globin prepared by 
the acid--acetone precipitation method [lo]. Pure 
abnormal fi chains were obtained by chromatography 
on carboxymethyl cellulose in urea according to Clegg 
[ 111, and globin chain electrophoresis was performed 
as described by R. G. Schneider [12]. The methods 
for analytical and preparative peptide mapping of 
tryptic digests of S. aminoethylated p chains either 
by fingerprinting [ 131 or by column chromatography 
[ 141 have been described. Amino acid analyses were 
carried out on a JEOL JLC 5 AH amino acid analyser. 
Peptides resulting from cyanogen bromide cleavage 
[IS] were fractionated on 0.9 X 200 cm columns of 
Sephadex G-50 (fine) equilibrated and developed with 
7% formic acid at a flow rate of 2 ml/h. Sequential 
analysis of amino acid residues was performed by the 
manual Edman degradation as previously described 
U61. 
3. Results and discussion 
3.1. Case report 
The association of a hemoglobin C trait with eryth- 
rocyte sickling was observed in a 40 year old African 
negro man who originated from Ziguinchor (Casamance, 
Senegal) and in two of the eight children of the pro- 
positus, whose slight clinical and hematological dis- 
orders will be described in a separate report. Blood 
smears showed target cells and the hemolysate 
presented no abnormalities in either its heat stability 
or isopropanol solubility, but was insoluble when 
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reacted at 20°C with Naz S2 04 in 2.24 M phosphate 
buffer, pH 6.8. Isolated Hb C Ziguinchor exhibited an 
oxygen equilibrium like that of Hb A, and in high 
concentration gelled on deoxygenation like Hb S, with 
subsequent liquefaction on cooling. 
3.2. Electrophoretic properties 
Electrophoresis of the proband’s hemolysate in 
Tris-EDTA-borate buffer at pH 8.6 revealed two 
hemoglobin bands (fig. 1 a), corresponding to Hb A and 
to the new variant Hb C Ziguinchor, which migrated 
slightly cathodally to the position of Hb C. However, 
it was not possible to separate it from Hb A2 under 
these conditions. Hb C Ziguinchor also travelled catho- 
dally to Hb C during electrophoresis in phosphate 
buffer at pH 6.5 (fig. 1 b). Electrophoresis in agar gel 
in citrate buffer at pH 6.2 showed Hb C Ziguinchor 
to be indistinguishable from Hb S. When the erythro- 
cyte hemolysate was electrophoresed on cellulose 
acetate in either acidic or alkaline buffer (pH 6.0 and 
8.9), in the presence of urea and 2-mercaptoethanol, 
the /3 chains of Hb C Ziguinchor migrated at a character- 
istic rate, which differed under acidic and alkaline 
conditions and distinguished them from hemoglobins 
C and E. Fig.2 illustrates the electrophoretic proper- 
ties of the different globin chains, and as previously 
described [ 12],pE moves very slightly cathodally to 
0 
PC in acidic buffer and slightly anodally to it in alka- 
line buffer. PC Ziguinchor moves more anodally than 
these two abnormal /3 chains both in alkaline and 
acidic media. These electrophoretic properties may 
provide a rapid means of characterising this new hemo- 
globin variant. 
3.3 Chrornatogruphic dutu 
In preliminary experiments, microcolumns of 
different ion exchange resins with appropriate develop- 
ers were used. We purified Hb C Ziguinchor on DEAE 
cellulose (DE--52) which had been equilibrated with 
a 0.05 M Tris-HCl buffer, pH 8.5. The abnormal hemo- 
globin was eluted after Hb Az at pH 8.3. This separa- 
tion of Hb C Ziguinchor from Hb Az subsequently 
allowed its quantitative measurement. The relative 
amount of the different hemoglobins was: Hb A = 
61.7% Hb Az = 3.3% and Hb C Ziguinchor = 35%. 
Complementary studies were performed in order to 
compare the specific mobilities of Hb C and Hb C 
Ziguinchor in CM-Sephadex [ 171 on a microcolumn, 
which was equilibrated and then developed with 0.05 
M Tris ~ maleic acid buffer pH 6.8. When a mixture 
of different hemoglobins was tested, Hb F was eluted 
from the resin in the first ml of buffer at pH 6.8; Hb A 
and Hb Az were both eluted at pH 7.2 just before Hb 
S, and Hb C Ziguinchor was subsequently eluted at 
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Fig.1. (A) Cellulose acetate strips electrophoresis (Tris-EDTA-borate buffer, pH 8.6, amino black stain) of hemolysates prepared 
from the following (left to right): (a) proband’s blood, (b) hemoglobin C trait, and (c) normal adult. (B) Cellulose acetate strips 
electrophoresis (phosphate buffer system, pH 6.5, amino black stain) of the following, left to right (1) adult with hemoglobin H 
disease, (2) adult with hemoglobin C trait, and (3) the propositus. (c. a. B denotes carbonic anhydrase B). 
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Fig.2. Globin-chain electrophoresis on cellulose acetate strips in urea-2mercaptoethanol buffers of pH 6.0 (A) and 8.9 (B), of 
hemolysates containing various hemoglobins. (A) Tris-EDTA-citrate buffer, pH 6.0, 225 V, 2 h. (B) Tris-EDTA-borate buffer 
pH 8.9, 300 V, 2 h. 
pH 7.4 Hb C is not normally eluted from the column 
under these conditions. 
3.4. Localisation of the substitution 
Comparison of peptide maps of tryptic digests of 
aminoethylated /3 C Ziguinchor with those prepared 
from normal 0 chains showed the following differences: 
(a) on the fingerprint at pH 6.4, /3 Tl was missing and 
a new peptide with a greater RF was present in a 
position resembling that of /3 Tl of Hb S. This spot 
gave a staining reaction for histidine. (b) The spot 
representing the peptide fl TS unexpectedly gave a 
staining reaction for arginine, and diminished staining 
with ninhydrin. (c) The /3 T6 spot stained with nin- 
hydrin less intensely than normal whereas the free 
Fig.3. Fingerprints of the tryptic peptides of the p chain of 
Hb C Ziguinchor (below) and Hb A (above). Electrophoresis 
was carried out at pH 4.7 for 2 h and followed by ascending 
chromatography. The dotted circle indicates the normal 
position of peptide p Tl. Numbers refer to tryptic peptides 
as designated in table I. 
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Table 1 
Amino acid composition of tryptic peptides 
P T5, l3 T5b-6 
October 1975 
__ ._ 
0 T6 
Sequence position 1 -8 41-58 59-61 60-61 
Lysine 
Histidine 
Arginine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Leucine 
Tyrosine 
Phenylalanine 
1.11 (1) 
0.80 (1) 
1.06 
3.19 
0.95 (11 0.90 
1.70 
1.14 (2) 1.05 
1.01 (1) 0.97 
2.06 
0.96 
1.78 (1) 1.03 
0.68 
1.20 (1) 1.15 
2.82 
1.98 (2) 1.01 (1) 
(3) 
(1) 
(2) 
(1) 
(2) 
(2) 
(1) 
(1) 1.02 (1) 0.98 (1) 
(1) 
(1) 
(3) 
Values in parenthesis indicate the amino acid composition of the corresponding sequences in the isolated pA chain. 
lysine spot (0 T8) showed an increased intensity of 
ninhydrin staining. When electrophoresis was run at 
pH 4.7 (fig.3) instead of pH 6.4, a supplementary pep- 
tide spot was seen, which did not stain for histidine 
and was situated between peptides /3 T8 and /3 T6. Ana- 
lysis of this peptide showed that it had the composi- 
tion Lys (2) Val(1) (Table 1). Fig.4 shows the pattern 
of tryptic peptides of abnormal fl chains obtained by 
Aminex A5 (Bio Rad) chromatography. The pattern 
is the same as for a normal fi chain except for the 
cross-hatched zones. Table 1 gives the amino acid 
composition of abnormal peptides. The relative amount 
of amino acids in the analysis of p Tl corresponds to 
that expected in fls Tl. Analysis of/j T5 showed that 
the abnormal peptide differed in having one residue 
of proline instead of two, and a residue of arginine 
instead of lysine, with one less amino acid residue 
than normal (0 T5a). Peptides p T5a (/3 41-58) and 
p TSb (/3 59 Lys) are the result of the tryptic hydro- 
lysis of the peptide bond between fl 58 Arg and /3 59 
Lys. Incomplete cleavage of the /3 59S60 peptide bond 
(as a result of the adjacent Arg 0 58) explains the 
presence of peptide fi T5,-6, where p 59 Lys remains 
attached to the following peptide. The penultimately 
eluted peptide from the cation-exchange resin (fig.4) 
corresponds to the abnormal spot found on the finger- 
Fig.4. Peptide pattern of the tryptic hydrolysate of 30 mg of aminoethylated p chain from hemoglobin C Ziguinchor. Chromato- 
graphic separation was obtained on a column of Aminex A5 cationexchange resin developed with a gradient of pyridine-acetic 
buffers from pH 3.1 to pH 5.0. The numbers above the zones identify the tryptic peptides found therein. 
152 
Volume 58, number 1 FEBS LETTERS October 1975 
print performed at pH 4.7. Since there is no change in 
the overall electric charge of the new /3 TS, and since 
the removal of a proline residue from this moderately 
large peptide might have little effect on its chromato- 
graphic behaviour, no positional abnormality was 
found either on the chromatographic pattern or on 
the finger print maps. In order to confirm the two 
substitutions by manual Edman degradation, and to 
facilitate sequence analysis of the two regions in which 
the structural abnormalities were known to reside, the 
abnormal p chain of the proband was subjected to 
specific cleavage at methionyl residue (b 55) with 
cyanogen bromide. Gel filtration of the products 
separated the two major fragments. Edman degrada- 
tion of each peptide gave the following sequences: 
NH2 terminal- 
1 23456789 
Val-His-Leu-Thr-Pro-Val-Glu-Lys--Ser. . . . -r-,,7 
56 57 58 59 60 61 
and N-zy-g-A+-Lys-Val-Lys. . . . 
7 
This demonstrates that the actual structure of Hb C 
Ziguinchor is /3 Glu (A3)6 + Val, p Pro (E2) 58 + Arg. 
The replacement 0 58 Pro -+ Arg was previously 
described by Marengo-Rowe et al. [3] for hemoglo- 
bin Dhofar, and by Yanase et al. [4] for hemoglobin 
Yukuhashi. 
4. Conclusions 
The occurence of two substitutions in a single 
polypeptide chain of hemoglobin has been previously 
observed in the case of Hb C Harlem [ 1 ] in an 
American negro family of African descent, and in Hb 
J Singapore [2]. The new hemoglobin variant described 
here also contains two amino acid substitutions in the 
/3 chain with one, f16 Val, responsible for sickling, as 
in Hb C Harlem. The second substitution, p 58 Pro 
-+ Arg, has been described for Hb Dhofar [3] in a 
South Arabian Veddoid from the Qara mountains of 
Dhofar, and for Hb Yukuhashi (41 in a Japanese 
person. These two substitutions, which are consistent 
with a one step mutation (a single base substitution) 
in the triplet code of messenger RNA, could have 
originated either by a second mutation in a /3 chain 
which already carried a single mutation for either the 
6 or 58 residue, or could have resulted from homologous 
crossing over in an individual who was doubly hetero- 
zygote for Hb S and for Hb Dhofar (c$ 0, 58 Arg). 
In connection with this latter suggestion it should 
be noted that Hb S occurs in 40 per cent of the 
population in certain areas of Africa and that 90 per 
cent of the population of Senegal are of the Muslim 
religion as are the people of Dhofar. The distance 
between determinants for p6 and /3”, although smaller 
than those between p6 and p73 of Hb C Harlem, 
nevertheless might favor crossing over between the two 
sites. Examination of the tertiary structure shows that 
the second substitution p5* Arg occurs at a corner and 
at the beginning of the E helix (E2). E2 is a non-polar 
residue in all chains of known hemoglobins, but its 
replacement by the polar arginine does not seem to 
be of particular importance in the structure of the 
variant fl chain [ 181, and does not explain the low 
proportion (15%) of Hb Dhofar in the heterozygote 
[3], since Hb Yukuhashi surprisingly constituted 56 
per cent of the total hemoglobin in the heterozygote. 
There is no significant decrease in the proportion of 
Hb C Ziguinchor (35%) as expected for a /3 chain 
variant. Another hypothesis which might explain the 
phenotype Dhofar arises from the possible association 
with a gene for o thalassemia. Hb C Ziguinchor 
retains many properties of Hb S (sickling, gelation and 
relative insolubility in its deoxy form), but in con- 
trast to Hb C Harlem, a detailed comparison of these 
properties does not reveal differences resulting from 
the second substitution. A separate report will describe 
these studies, together with the hematological and 
clinical findings associated with this new hemoglobin 
variant. 
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